Sponsors

www.sjm.com

St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 14,000 people worldwide and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation.

The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, vascular closure devices, heart valve replacement and repair products, and neurostimulation devices.

Atrial fibrillation: St. Jude Medical is the only medical device company to dedicate a business unit solely to diagnosing, treating and curing atrial fibrillation (AF), the world's most common cardiac arrhythmia. Technology such as the EnSite Fusion cardiac imaging system, which creates detailed images of the heart to help physicians diagnose and treat cardiac arrhythmias, demonstrates St. Jude Medical's leadership in this area.

Our Mission Statement
It is our mission to develop medical technology and services that put more control into the hands of those who treat cardiac, neurological and chronic pain patients, worldwide. We do this because we are dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient.

www.atritech.net

BWATCHMAN® Left Atrial Appendage (LAA) Closure Technology is a device alternative to warfarin therapy for patients with non-valvular atrial fibrillation.

Patients with atrial fibrillation are at a significantly greater risk of having a stroke due to embolization of clots that may form in the left atrial appendage.

By closing off the left atrial appendage, the WATCHMAN technology is designed to reduce embolization of thrombi that may form in the LAA, reducing the risk of stroke, cardiovascular death and systemic thromboembolism.

www.crbard.com

Bard Electrophysiology is a global company focused on the development and delivery of a broad range of devices for the diagnosis and treatment of cardiac arrhythmias, including Atrial Fibrillation in markets outside of the US.

Bard EP offers the Electrophysiologist a full product portfolio which includes advanced RF ablation and mapping catheters, diagnostic catheters, computer based electrophysiology mapping and recording systems, temporary pacing electrodes, and vascular/cardiac access devices.

www.biosensewebster.com

Biosense Webster, Inc., a Johnson & Johnson company, pioneered electrophysiology diagnostic catheters more than 30 years ago and continues to lead the industry as an innovative provider of advanced diagnostic, therapeutic and mapping tools. As the leader in navigation systems and ablation therapy, Biosense Webster, Inc.'s technology includes the largest installed base of navigation systems worldwide in leading hospitals and teaching institutions. With proprietary products such as the CARTO® 3 System, the CARTO® XP System, the CARTOSOUND™ Image Integration Software Module, the THERMOCOOL® Irrigated Tip Catheter and the LASSO® Circular Variable Mapping Catheter, the company is changing the way electrophysiologists diagnose and treat arrhythmias.

www.biotronik.com

BIOTRONIK SE & Co. KG
As one of the world's leading cardiovascular medical device companies, with several million implanted devices, BIOTRONIK is represented in over 100 countries with its global work force of more than 4,900 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face, and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management.
Quality, innovation and reliability define BIOTRONIK and its growing success, and deliver confidence and peace of mind to physicians and their patients worldwide.

www.boehringeringelheim.com

Iringer Ingelheim group is one of the world's 20 leading pharmaceutical companies.

Headquartered in Ingelheim, Germany, it operates globally with 41,300 employees in 138 affiliated companies worldwide.

Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2008, Boehringer Ingelheim posted net sales of €11,595 million while Research and Development expenditure increased by 11% on the previous year. Boehringer Ingelheim is one of the fastest growing pharmaceutical companies worldwide, achieving a 2% share of the world market.

bostonscientific-international.com

Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 25,000 employees and revenue of $8.050 billion in 2008. For more than 25 years, Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. The Company’s products help physicians and other medical professionals improve their patients’ quality of life by providing alternatives to surgery. For more information, please visit www.bostonscientificinternational.com.

 
www.cardiofocus.com

Visually guided catheter ablation of atrial fibrillation is now a reality. The CardioFocus compliant balloon catheter fits a wide range of anatomies and delivers a true one-size-fits-all capability. The balloon houses a built-in microendoscope which allows you to see unique, full color, real-time, 360-degree movies of the cardiac anatomy to show exactly where the energy will be directed before any energy is delivered. Visually guided light energy allows physicians to reliably achieve durable pulmonary vein electrical isolation at the level of the antrum in patients with highly variable PV shapes and sizes. Ablate what you see…See what you ablate.

www.cardiologic.com

Cardiologic Ltd are delighted to present two leading EP technology companies at Europe AF 2009.
CathRX, a new Australian EP company with their new range of unique versatile catheter systems for left and right side procedures including their new Loop pulmonary vein mapping catheter.
Atricure, the leader in surgical AF ablation, and their range of tools for surgical Video Assisted Thorascopic pulmonary vein isolation and the new unique Left Atrial Appendage isolation clip.

Visit us at Stand 15 for a glimpse of our vision of the future of AF treatment.

www.endosense.com

Founded in Geneva in 2003, Endosense is a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac arrhythmias. The company has pioneered the use of contact force measurement in catheter ablation, with the development of its proprietary Touch+® sensor technology. Endosense's flagship product is the TactiCath®, the first force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. The TactiCath has received CE Mark Approval in May 2009 and commercialization release in Europe is underway. For more information, visit www.endosense.com.

www.hansenmedical.com

Hansen Medical develops and manufactures a new generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and atheter-based technologies. The Sensei™ Robotic Catheter System and the Artisan™ Control Catheter allow physicians to instinctively navigate flexible catheters with greater stability and control during interventional procedures.

www.medtronic.com

Medtronic is the global leader in medical technology, focused on delivering leading edge diagnostics and therapies in the management of a broad spectrum of cardiac disorders including arrhythmias, structural heart and vascular diseases. Visit our stand to find out more about our Electrophysiological and CRDM range of solutions for the accurate diagnosis, treatment and monitoring of arrhythmias.

www.sanofi-aventis.com 

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone.

In the UK sanofi-aventis is a dynamic, rapidly growing organisation that is working to meet the needs of healthcare professionals and their patients.

Our portfolio of products closely match the priorities of health services throughout Europe and include cardiovascular disease, thrombosis, metabolic disorders, central nervous system disorders, oncology, internal medicine and
vaccines.